GOLDMAN SACHS GROUP INC - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 67 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$535,624
+26.7%
135,601
+0.4%
0.00%
Q2 2023$422,854
-47.2%
135,097
-23.6%
0.00%
Q1 2023$801,271
+72.2%
176,881
+57.0%
0.00%
Q4 2022$465,393
+138.7%
112,686
+84.9%
0.00%
Q3 2022$195,000
+29.1%
60,930
+366.8%
0.00%
Q3 2021$151,000
+7.1%
13,053
-8.8%
0.00%
Q2 2021$141,00014,3140.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 2,746,265$12,440,5803.30%
Opaleye Management Inc. 1,401,000$6,346,5301.90%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,941,357$76,744,3471.71%
GREAT POINT PARTNERS LLC 900,000$4,077,0000.80%
DAFNA Capital Management LLC 236,873$1,073,0350.32%
Perceptive Advisors 2,280,709$10,331,6120.30%
Atlas Venture Advisors, Inc. 292,184$1,323,5940.28%
MANGROVE PARTNERS IM, LLC 805,815$3,650,3420.24%
Verition Fund Management LLC 1,938,822$8,782,8640.12%
Woodline Partners LP 1,681,913$7,619,0660.10%
View complete list of LARIMAR THERAPEUTICS INC shareholders